| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 435.41▲ | 436.63▼ | 437.84▼ | 453.15▼ | 449.54▼ |
| MA10 | 435.32▲ | 439.06▼ | 442.31▼ | 451.53▼ | 454.61▼ |
| MA20 | 436.21▲ | 443.58▼ | 450.33▼ | 451.61▼ | 430.94▲ |
| MA50 | 438.36▼ | 454.52▼ | 454.92▼ | 457.32▼ | 332.15▲ |
| MA100 | 442.20▼ | 455.21▼ | 447.62▼ | 428.24▲ | 270.65▲ |
| MA200 | 450.05▼ | 447.40▼ | 458.91▼ | 349.13▲ | 228.11▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.182▲ | -0.488▼ | -1.909▼ | -0.330▼ | -6.688▼ |
| RSI | 46.802▼ | 29.844▼ | 28.959▼ | 41.029▼ | 59.600▲ |
| STOCH | 58.498 | 12.794▼ | 8.514▼ | 58.478 | 41.760 |
| WILL %R | -47.860 | -83.171▼ | -91.945▼ | -62.809 | -75.328▼ |
| CCI | 52.312 | -110.333▼ | -117.698▼ | -51.822 | -88.201 |
| ▼ MACD | $ALNY MACD(12,26,9) Crossed Below Signal Line | Set Alert |
|
Friday, November 21, 2025 02:51 AM
The UK subsidiary Alnylam welcomed positive Final Draft Guidance issued by the National Institute for Clinical Health and care Excellence (NICE) has recommending the firm’s Amvuttra (vutrisiran) for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/11/25 | 448.23 | 449.53 | 433.50 | 436.38 | 1,297,774 |
| 20/11/25 | 463.32 | 467.73 | 445.34 | 445.79 | 781,704 |
| 19/11/25 | 462.27 | 465.32 | 456.90 | 460.76 | 890,287 |
| 18/11/25 | 458.15 | 469.11 | 456.27 | 462.30 | 659,006 |
| 17/11/25 | 449.00 | 463.92 | 449.00 | 460.54 | 962,065 |
| 14/11/25 | 453.87 | 461.96 | 448.28 | 449.16 | 966,150 |
| 13/11/25 | 450.67 | 456.14 | 447.12 | 453.97 | 679,819 |
| 12/11/25 | 450.63 | 459.2699 | 446.71 | 452.74 | 851,730 |
| 11/11/25 | 443.53 | 455.20 | 441.21 | 451.95 | 904,706 |
| 10/11/25 | 445.00 | 449.68 | 440.93 | 441.70 | 738,934 |
|
|
||||
|
|
||||
|
|